Healthcare stocks advanced 0.3% at midday Tuesday. The Reserve Bank of Australia is expected to announce the anticipated interest rate decision later on the same day.
Opthea (ASX:OPT) completed the final week-52 patient visit in Coast, the first of two phase three trials evaluating a combination therapy candidate for wet age-related macular degeneration, an eye disease that can blur vision.
On the other hand, energy stocks were down 1.7%. Woodside Energy Group (ASX:WDS) extended losses from the Monday trading session, after it implied its final dividend could fall below expectations by as much as 20%.
Woodside held talks with several potential buyers of stakes in its Louisiana liquefied natural gas plant, including Tokyo Gas, Japan's JERA, and MidOcean Energy, Reuters reported citing multiple sources.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。